Funtleyder on Lilly's Alzheimer's Drug

Oct. 9 (Bloomberg) -- Les Funtleyder, president of the investment advisory division at Poliwogg, talks about Eli Lilly & Co.'s experimental Alzheimer's treatment, the Alzheimer's drug market and the outlook for Lilly and PDL BioPharma Inc. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." Bloomberg's Shannon Pettypiece also speaks. (Source: Bloomberg)

Twitter Fights Online Terrorism, 125K Accounts Suspended
48:30 - Bloomberg’s Sarah Frier discusses Twitter suspending 125,000 accounts for promoting terrorism. She speaks with Bloomberg’s Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Three Charts That Examine the Week of Woes for Oil
  • Has the Unemployment Drop Rekindled Rate Concern?
  • Three Bright Spots in U.S. Jobs Report